In this study, we uncover a previously unknown mechanism by which TTK exerts a significant oncogenic effect by the upregulation of neurotensin (NTS) and dihydropyrimidinase-like 3 (DPYSL3), which promote cancer growth and cancer progression consequently tumor metastasis. The gene discussed is TTK; the disease is cancer.